| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/19/2014 | CN102935075B 头孢地尼胶囊及其制备方法 Cefdinir capsules and its preparation method |
| 02/19/2014 | CN102920694B Pharmaceutical composition with anti-tumor effect and preparation thereof |
| 02/19/2014 | CN102920678B Olanzapine solid preparation with high adsorbility and bioavailability and preparation method thereof |
| 02/19/2014 | CN102908373B Extraction method of total eoumarins in Chinese medicament common cnidium fruit |
| 02/19/2014 | CN102885930B Externally applied cream for treating toothache caused by heat |
| 02/19/2014 | CN102885846B Application of 2-thio-6-azauridine in preparation of anti-human-immunodeficiency-virus-1 (HIV-1) medicine |
| 02/19/2014 | CN102861208B Antibacterial, anti-inflammation and antiviral traditional Chinese medicine compound |
| 02/19/2014 | CN102836287B Chinese medicinal ointment for treating scar and preparation method thereof |
| 02/19/2014 | CN102796113B Xanthone compound, and preparation method and application thereof |
| 02/19/2014 | CN102772583B Heat clearing tablet and preparation method thereof |
| 02/19/2014 | CN102764330B Medicine composition for treating cutaneous pruritus and preparation method thereof |
| 02/19/2014 | CN102743458B Formula of health drug with effects blood fat regulating and immunity increasing |
| 02/19/2014 | CN102727470B Application of fluorene-9-bisphenol and its derivative in preparation of medicine for preventing and treating cancer |
| 02/19/2014 | CN102718751B Pantoprazole salt crystal form and preparation method thereof |
| 02/19/2014 | CN102697721B Salidroside segmented copolymer lipid nanoparticle preparation |
| 02/19/2014 | CN102688196B Omeprazole pellets and preparation method thereof |
| 02/19/2014 | CN102670619B Cefalexin-borneol composition |
| 02/19/2014 | CN102659818B Hydrochloric acid cefotiam crystalline compound, preparation method thereof and medicine combination containing compound |
| 02/19/2014 | CN102647908B Combination |
| 02/19/2014 | CN102612367B Prolyl hydroxylase inhibitors |
| 02/19/2014 | CN102579455B Stable cefaclor chewing composition |
| 02/19/2014 | CN102579419B Novel anticancer application of chlorogenic acid |
| 02/19/2014 | CN102574781B 2,3-dihydro-1h-indene-2-ylurea derivative and pharmaceutical application of same |
| 02/19/2014 | CN102552152B Veterinary doxycycline hydrochloride-polymer composite particle and preparation method thereof |
| 02/19/2014 | CN102532218B Strictosidine-like alkaloid as well as preparation method and application thereof |
| 02/19/2014 | CN102526346B Health-care pharmaceutical formulation with immunity-enhancing and senility-delaying functions |
| 02/19/2014 | CN102526003B New application of tetrahydrocurcumin |
| 02/19/2014 | CN102512512B Preparation method for self-assembly medical composite facial mask |
| 02/19/2014 | CN102503953B Oximes compound |
| 02/19/2014 | CN102481288B Pharmaceutical composition of temozolomide comprising amino acid stabilizer and preparation method thereof |
| 02/19/2014 | CN102452951B Agomelatine and pharmaceutical composition thereof |
| 02/19/2014 | CN102391335B Isopentene flavonol glycoside derivative and preparation method and application thereof |
| 02/19/2014 | CN102372659B Indolebenzamide derivatives and medicinal applications thereof |
| 02/19/2014 | CN102356061B Method for producing bicyclic g-amino acid derivative |
| 02/19/2014 | CN102344438B Crystals of quinoline derivative and preparation methods thereof |
| 02/19/2014 | CN102341708B Screening method for epidermal growth factor receptor tyrosine kinase inhibitor and inhibitors identified using same |
| 02/19/2014 | CN102311448B Thieno-pyrimidone DPP-IV (dipeptidyl peptidase) inhibitor |
| 02/19/2014 | CN102309622B Application of total glycosides of verbena in preparation of medicines for controlling cerebral ischemia |
| 02/19/2014 | CN102267929B Preparation of novel N-amino acid substituted azulene sulfamide medicine and anti-gastric ulcer actions thereof |
| 02/19/2014 | CN102210759B Application of Chinese medicinal component in preparation of nitric oxide donor medicament |
| 02/19/2014 | CN102060882B Dehydrogenated clindamycin phosphate, analysis preparation method and application thereof |
| 02/19/2014 | CN102048717B Stable rasagiline composition |
| 02/19/2014 | CN102007104B The polymorphs of 4-anilinoquinazoline derivatives, the preparation methods and uses thereof |
| 02/19/2014 | CN101878022B A method for producing adapalene gels |
| 02/19/2014 | CN101856313B Association of monosaccharides and adenosine and its cosmetic use |
| 02/19/2014 | CN101827836B Trisubstituted 1,2,4-triazoles |
| 02/19/2014 | CN101766605B Pramipexole-contained pharmaceutical composition capable of being dispersed in mouth |
| 02/19/2014 | CN101506138B Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof |
| 02/18/2014 | USRE44768 Rapamycin hydroxyesters |
| 02/18/2014 | US8653304 2,3-dihydro-1H-indene-2-yl urea derivative and pharmaceutical application of same |
| 02/18/2014 | US8653299 Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators |
| 02/18/2014 | US8653285 Aminopropylidene derivative |
| 02/18/2014 | US8653276 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin II receptor antagonists |
| 02/18/2014 | US8653275 Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors |
| 02/18/2014 | US8653272 Fused pyridine derivatives as kinase inhibitors |
| 02/18/2014 | US8653271 Enhancing transdermal delivery of opioid antagonists and agonists using codrugs linked to bupropion or hydroxybupropion |
| 02/18/2014 | US8653268 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 02/18/2014 | US8653263 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators |
| 02/18/2014 | US8653259 Process for synthesizing heterocyclic compounds |
| 02/18/2014 | US8653257 Dibenzothiazepine derivatives and uses thereof—424 |
| 02/18/2014 | US8653255 Sialic acid derivatives for protein derivatisation and conjugation |
| 02/18/2014 | US8653146 Method for treating Th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor |
| 02/18/2014 | US8653145 Method for alleviating climacteric symptoms |
| 02/18/2014 | US8653144 Treatment of pervasive developmental disorders with redox-active therapeutics |
| 02/18/2014 | US8653143 Use of panduratin derivative or Boesenbergia pandurata extract |
| 02/18/2014 | US8653142 Styrenyl derivative compounds for treating ophthalmic diseases and disorders |
| 02/18/2014 | US8653141 HIV protease inhibiting compounds |
| 02/18/2014 | US8653140 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
| 02/18/2014 | US8653139 Drug substance preparations, pharmaceutical compositions and dosage forms |
| 02/18/2014 | US8653138 Calcium salts of compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/18/2014 | US8653137 Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same |
| 02/18/2014 | US8653136 Compositions based on amino acids for improving the myocardial ventricular function in patients suffering from diabetes |
| 02/18/2014 | US8653135 Alternating sympathomimetic therapy for the treatment of respiratory aliments |
| 02/18/2014 | US8653134 Hydroxyphenol derivatives, processes for the preparation thereof, pharmaceutical compositions them, and therapeutic uses thereof |
| 02/18/2014 | US8653133 Crystalline ingenol mebutate |
| 02/18/2014 | US8653132 Phosphaplatins and their use in pharmaceutical compositions |
| 02/18/2014 | US8653131 Polymeric benzyl carbonate-derivatives |
| 02/18/2014 | US8653129 Combination therapy for skin disorders |
| 02/18/2014 | US8653127 Bicyclic pyrazolo-heterocycles |
| 02/18/2014 | US8653126 Imidazole derivative |
| 02/18/2014 | US8653125 Cyclohexane derivative having NPY Y5 receptor antagonism |
| 02/18/2014 | US8653124 Inhibition of bacterial biofilms with imidazole derivatives |
| 02/18/2014 | US8653123 Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases |
| 02/18/2014 | US8653122 Oromucosal formulation and process for preparing the same |
| 02/18/2014 | US8653120 Method for treatment of chronic neuropathic pain |
| 02/18/2014 | US8653119 Methods for treating transthyretin amyloid diseases |
| 02/18/2014 | US8653118 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
| 02/18/2014 | US8653117 Composition comprising at least one oxazoline to inhibit migration of langerhans cells, and uses thereof |
| 02/18/2014 | US8653115 Heterocyclic non-nucleoside compounds, their preparation, pharmaceutical composition and their use as antiviral agents |
| 02/18/2014 | US8653113 Fungicidal composition and method for controlling plant diseases |
| 02/18/2014 | US8653112 Substituted pyrazoles as estrogen receptor ligands |
| 02/18/2014 | US8653111 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases |
| 02/18/2014 | US8653110 Active compound combination comprising azadirachtin and a substituted enaminocarbonyl compound |
| 02/18/2014 | US8653109 Substituted bipyridine derivatives and their use as adenosine receptor ligands |
| 02/18/2014 | US8653108 Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors |
| 02/18/2014 | US8653107 Fentanyl composition for nasal administration |
| 02/18/2014 | US8653106 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder |
| 02/18/2014 | US8653105 Quinoline derivatives as kinase inhibitors |
| 02/18/2014 | US8653104 PTEN inhibitor or Maxi-K channels opener |
| 02/18/2014 | US8653103 Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |